Lauding the initiatives taken by the Indian Healthcare sector in the fight against COVID, Prime Minister Narendra Modi asserted that the global trust earned by the Indian healthcare sector has given India the recognition of 'pharmacy of the world'. PM Modi inaugurated the First Global Innovation Summit of the Pharmaceuticals sector via video conferencing on Thursday, November 18.
Discoursing at the summit, PM Modi said that since the last two years, every aspect of the healthcare sector in the country has received attention, be it lifestyle or vaccines.
In this context, the Indian pharmaceutical industry has also risen to the challenge. The global trust earned by the Indian healthcare sector has led to India being called the 'pharmacy of the world' in recent times,' PM Modi said.
The Prime Minister said that the combination of 'high quality and quantity' at affordable prices has sowed the seeds of global interest in the Indian pharmaceutical sector. He added that the sector has attracted over USD 12 billion in FDI since 2014.
Prime Minister Modi addressing the pharma summit said that India has exported more than 65 million doses of COVID vaccines to nearly 100 countries this year and that it has exported lifesaving medicines and medical equipment to over 150 countries during the initial phase of the Coronavirus pandemic. He further added that with an increase in the production of vaccines over the coming months, the country is set to do much more.
Our definition of wellness is not limited by physical boundaries. We believe in the well-being of the entire humankind. And, we have shown this spirit to the whole world during the COVID-19 global pandemic,' the Indian Prime Minister said.
PM Modi said that the government intends to create an ecosystem that will make India a leader in drug recovery and innovation in medical devices. 'We're sensitive to industry demands on regulatory frameworks & actively working in this direction,' he added.
Prime Minister Narendra Modi welcomed global Pharma Industries to ideate, innovate and make in India. He said that India has the talent, resources, and ecosystem that is needed for innovation and industry.
The Prime Minister's Office (PMO) informed that Global Innovation Summit is a distinctive initiative that aims to bring together key Indian and international stakeholders from the government, industry, academia, investors, and researchers to discuss and strategise priorities to foster a thriving innovation ecosystem in the pharmaceuticals industry in India. It will also highlight the opportunities in the Indian pharma industry that has huge growth potential, it said.
The two-day pharma summit will be holding 12 sessions. More than 40 national and international speakers will be deliberating on a range of subjects including the regulatory environment, funding of innovation, industry-academia collaborations, and innovation infrastructure.
It will be witnessing the participation of leading representatives from domestic and global Pharma Industries, officials, investors, and researchers from the Massachusetts Institute of Technology (MIT), John Hopkins Institute, IIM Ahmedabad, and other revered institutes.
This article was originally published on Republic world
